You just read:

XTL Biopharmaceuticals Expands Clinical Advisory Board to Support Phase II Study of HCDR1 in Sjogren's Syndrome

News provided by

XTL Biopharmaceuticals Ltd

13 Feb, 2017, 09:08 ET